1. Юкина М.Ю., Трошина Е.А., Платонова Н.М., Бельцевич Д.Г. Надпочечниковая недостаточность. В кн.: Трошина Е.А. Сборник методических рекомендаций (в помощь практическому врачу) – Тверь: Триада, 2017. – С. 149-192.
2. Ramos-Prol A., Rubio-Almanza M., Campos-Alborg V., Febrer-Bosch I., Merino-Torres J.F. Chronic autoimmune urticaria as a possible non endocrine manifestation of autoimmune polyglandular syndrome type II. Endocrinol Nutr. 2011; №58 (9):497-505.
3. Anaya J.M. The diagnosis and clinical significance of polyautoimmunity. Autoimmunity Reviews. 2014; №13 (4–5):423-426.
4. Cojocaru M., Cojocaru I.M., Silosi I. Multiple autoimmune syndrome. Maedica (Buchar). 2010; №5 (2):132–134.
5. Husebye E.S., Perheentupa J., Rautemaa R., Kampe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med. 2009; №265:514–29.
6. Martín-Campagne E., Ballester-Herrera M.J., Palomo-Atance E., Sánchez-Ruiz P., Giralt-Muiña P. Hyponatremic rhabdomyolysis in Addison’s disease in a child with autoimmune polyglandular syndrome type 2. Endocrinol Nutr. 2015; №62:511-512.
7. Al-sharefi A., Khan U., Tarigopula G., Peter P., Kamaruddin S., Partha P. Late Onset Diabetes of Adults (LADA) Masked By Coexistent Adrenal Failure in the Context of Autoimmune Polyglandular Syndrome 2. Journal of Diabetes, Metabolic Disorders & Control. 2016; №3 (3):00070.
8. Betterle C., Garelli S., Coco G., Burra P. A rare combination of type 3 autoimmune polyendocrine syndrome (APS-3) or multiple autoimmune syndrome (MAS-3). Auto Immun Highlights. 2014; №5 (1):27-31.
9. Naletto L., Frigo A., Ceccato F., Sabbadin C., Scarpa R., Presotto F., Dalla Costa M., Faggian D., Plebani M., Censi S., Manso J., Furmaniak J., Chen S., Rees Smith B., Masiero S., Pigliaru F., Boscaro M., Scaroni C., Betterle C. The natural history of autoimmune Addison's disease from the detection of autoantibodies to development of the disease: a long follow-up study on 143 patients. Eur J Endocrinol. 2019. pii: EJE-18-0313.R3.
10. Gherbon A. Prevalence of polyglandular autoimmune syndrome type iii in a group of adults with thyroid diseases and diabetes mellitus. 1st Annual International Interdisciplinary Conference, AIIC 2013, 24-26 April, Azores, Portugal.
11. Husebye E.S., Anderson M.S., Kämpe O. Autoimmune Polyendocrine Syndromes. N Engl J Med. 2018; №378 (12):1132–1141.
12. Bornstein S.R. Predisposing factors for adrenal insufficiency. N Engl J Med. 2009; №360:2328-2339.
13. Rashidi A., Fisher S.I. Primary adrenal lymphoma: a systematic review. Ann Hematol. 2013;№92 (12):1583-93.
14. Laurent C., Casasnovas 0., Martin L., Chauchet A., Ghesquieres H., Aussedat G., Fornecker L., Bologna S., Borot S., Laurent K., Bouillet B., Verges B., Petit J-M. Primary Adrenal Lymphoma: presentation, management and prognosis. QJM. 2017;№110 (2):103-109.
15. Gonzalez-Rodriguez E., Rodriguez-Abreu D., Spanish Group for Cancer I-B. Immune checkpoint inhibitors: review and management of endocrine adverse events. Oncologist. 2016; №21 (7):804-816.
16. Colombo C, De Leo S, Di Stefano M, Vannucchi G, Persani L, Fugazzola L. Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy. J Clin Endocrinol Metab. 2019: №104 (3):779-784.
17. Allolio B. Extensive expertise in endocrinology: adrenal crisis. Eur J Endocrinol. 2015; №172 (3):R115-R124.
18. Фадеев В.В., Мельниченко Г.А. Haдпoчeчникoвaя недостаточность (клиника, диагностика, лечение). Методические рекомендации для врачей. Москва: Meдпpaктикa-M; 2003.
19. Дедов И.И., Мельниченко Γ.A., Фадеев B.B. Эндокринология. 3-е изд., пepepaб. и доп. - Москва: Литтeppa; 2015.
20. Chakera А. J., Vaidya В. Addison disease in adults: diagnosis and management. Am J Med. 2010; №123:409-413.
21. Erichsen M.M., Løvås K., Skinningsrud B., Wolff A.B., Undlien D.E., Svartberg J., Fougner K.J., Berg T.J., Bollerslev J., Mella B., Carlson J.A., Erlich H., Husebye E.S. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab. 2009; №94 (12):4882-90.
22. Charmandari E., Nicolaides N.C., Chrousos G.P. Adrenal insufficiency. Lancet. 2014; №383 (9935):2152-2167.
23. Meyer G., Neumann К., Badenhoop К., Linder R. Increasing prevalence of Addison's disease in German females: health insurance data 2008-2012. Eur J Endocrinol. 2014; №170:367-373.
24. Quinkler M., Beuschlein F., Hahner S., Meyer G., Schöfl С, Stalla G.K. Adrenal cortical insufficiency—a life threatening illness with multiple etiologies. Dtsch Arztebl Int 2013; №110 (51-52): 882-8.
25. Bleicken B., Hahner S., Ventz M., Quinkler M. Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients. Am J Med Sci. 2010; №339:525–531.
26. Bornstein S.R., Allolio B., Arlt W., Barthel A., Don-Wauchope A., Hammer G.D., Husebye E.S., Merke D.P., Murad M.H., Stratakis C.A., Torpy D.J. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016; №101 (2):364-89.
27. Oelkers W., Diederich S., Bähr V. Diagnosis and therapy surveillance in Addison’s disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone. J Clin Endocrinol Metab. 1992; №75:259–264.
28. Oelkers W. Adrenal insufficiency. NEngl J Med. 1996; №335:1206–1212.
29. Jones D.A., Miras A., Tringham J.R. Addison’s disease: a diagnostic challenge. Br J Hosp Med (Lond). 2008; №69:M192–M195.
30. Oelkers W., Boelke T., Bähr V. Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1 –39) or human corticotropin-releasing hormone in man. J Clin Endocrinol Metab. 1988; №66:181–186.